dc.contributor.author | Gonzalez-Jimenez, Irene | |
dc.contributor.author | Lucio, Jose | |
dc.contributor.author | Menéndez-Fraga, Maria Dolores | |
dc.contributor.author | Mellado, Emilia | |
dc.contributor.author | Peláez, Teresa | |
dc.date.accessioned | 2021-01-26T09:26:38Z | |
dc.date.available | 2021-01-26T09:26:38Z | |
dc.date.issued | 2021-01-02 | |
dc.identifier.citation | J Fungi (Basel) . 2021 Jan 2;7(1):22 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/11676 | |
dc.description.abstract | Azole-resistant Aspergillus fumigatus is an emerging worldwide problem with increasing reports of therapy failure cases produced by resistant isolates. A case of azole-resistant A. fumigatus hospital colonization in a patient is reported here. Investigations of the hospital environment led to the recovery of A. fumigatus strains harboring the TR34/L98H and the G448S Cyp51A azole resistance mechanisms. Isolate genotyping showed that one strain from the environment was isogenic with the patient strains. These are the first environmental A. fumigatus azole resistant strains collected in a hospital in Spain; it supports the idea of the hospital environment as a source of dissemination and colonization/infection by azole resistant A. fumigatus in patients. The isolation of an azole-resistant strain from an azole-naïve patient is an interesting finding, suggesting that an effective analysis of clinical and environmental sources must be done to detect azole resistance in A. fumigatus. The emergence and spread of these resistance mechanisms in A. fumigatus is of major concern because it confers high resistance to voriconazole and is associated with treatment failure in patients with invasive aspergillosis. | es_ES |
dc.description.sponsorship | This research was funded by Fondo de Investigacion Sanitaria (FIS PI18CIII/00045) and also by Plan Nacional de I+D+i 2013–2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/CIII/0004/0003), co-financed by European Development Regional Fund ERDF “A way to achieve Europe”, Operative program Intelligent Growth 2014–2020. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Aspergillus fumigatus | es_ES |
dc.subject | Azole resistance mechanisms | es_ES |
dc.subject | cyp51A | es_ES |
dc.subject | Hospital environment | es_ES |
dc.title | Hospital Environment as a Source of Azole-Resistant Aspergillus fumigatus Strains with TR34/L98H and G448S Cyp51A Mutations. | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 33401764 | es_ES |
dc.format.volume | 7 | es_ES |
dc.format.number | 1 | es_ES |
dc.identifier.doi | 10.3390/jof7010022 | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | |
dc.contributor.funder | Ministerio de Economía y Competitividad (España) | |
dc.contributor.funder | Red de Investigación Cooperativa en Investigación en Patología Infecciosa (España) | |
dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 2309-608X | es_ES |
dc.relation.publisherversion | https://doi.org/10.3390/jof7010022 | es_ES |
dc.identifier.journal | Journal of fungi (Basel, Switzerland) | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/FIS PI18CIII/00045 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/REIPI RD16/CIII/0004/0003 | es_ES |
dc.rights.accessRights | open access | es_ES |